Tech Company Financing Transactions
WhiteLab Genomics Funding Round
WhiteLab Genomics, based in Evry, secured $10 million in investment from Debiopharm Diagnostics and OMNES Capital.
Transaction Overview
Company Name
Announced On
9/13/2022
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 rue Pierre Fontaine
Evry, 91000
France
Evry, 91000
France
Phone
Undisclosed
Website
Email Address
Overview
We are specialised in AI solutions for advanced therapies such as gene and cell therapies. Our team includes world-class data scientists specialized in AI and machine learning, computational biologists, molecular biologists and genomic medicine scientists.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Bourgo
Chief Scientific Officer
Julien Cottineau
Browse more venture capital transactions:
Prev: 9/13/2022: Patch venture capital transaction
Next: 9/13/2022: Redesign Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs